We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Overcoming Clinical Barriers to LAI Administration: Identification of the Negative Stigma Surrounding the Use of Injectable Antipsychotics
Christoph U. Correll, MD
Too Soon Is Not Soon Enough: Initiation of LAIs Sooner to Manage Symptoms of Suboptimally Treated Schizophrenia
Who’s on First: Accurate Recognition of Schizophrenia Candidates That Would Benefit From LAI Antipsychotic Therapy
Leslie Citrome, MD, MPH
Identifying and Managing Nonadherence to Antipsychotics in People with Schizophrenia
New and Emerging Treatment Paradigms for SCZ Symptom Management: One Size Does Not Fit All
RWE Where RCTs Fall Short: Optimizing Frontline Treatment of HR+/HER2- Metastatic Breast Cancer
Adam Brufsky, MD, PhD
Christopher M. Gallagher, MD
Balancing the Scales: The Complementary Roles of RCTs and RWE in Modern Healthcare
Distinguishing Between High- and Low-Quality RWE: A Journal Club for the Real World
RWE Supporting CDK4/6 Inhibitor Use in HR+ Metastatic Breast Cancer
Unlocking Insights for Underrepresented Patients: The Role of Real-World Evidence in Addressing Limitations of CDK4/6 Inhibitor RCTs
Importance of the Patient Perspective on RWE in Formulating SDM Conversations
Real World Use of RWE in HR+ Metastatic Breast Cancer: The Oncologist Perspective
Real World Evidence To Expand Knowledge of CDK4/6 Inhibitor-Related Adverse Effects
The NASH Epidemic: Highlights from the AMCP 2023 Symposium
Mazen Noureddin, MD, MHSc
Management of ADPKD
Neera Dahl, MD, PhD
Craig E. Gordon, MD
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education